Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for ORBACTIV
- Study to Evaluate the Safety and Tolerability of Single-Dose Intravenous (IV) Oritavancin
- Relative Exposure and Safety Study of Kimyrsa in ABSSSI Patients
- Safety of Either a Single or Two IV Doses of Orbactiv in Subjects With ABSSSI
- Study to Evaluate the Safety,Tolerability and Pharmacokinetics of a New Formulation of Oritavancin in Healthy Volunteers
- Multiple Oritavancin Doses on Safety, Tolerability, and Pharmacokinetics in Healthy Subjects
- A Study to Evaluate the Safety of a Single IV Dose of Orbactiv (Oritavancin) in Subjects on Chronic Warfarin Therapy Being Treated For Acute Bacterial Skin and Skin Structure Infection (ABSSSI)
- Drug-Drug Interaction Potential of Orbactiv (Oritavancin) Co-Administered With Warfarin in Healthy Subjects
Clinical trials list
click for details